Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,198.92. The company's market cap stands at 1.13T, with a P/E ratio of 42.09 and a dividend yield of 0.55%.
During the trading session on 2026-07-24, Eli Lilly(LLY) shares reached a daily high of $1,206.94 and a low of $1,180.39. At a current price of $1,198.92, the stock is +1.6% higher than the low and still -0.7% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 725.44K, versus its average volume of 2.3M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
Novo Nordisk (NVO) has escalated its feud with rival drug maker Eli Lilly (LLY) by seeking a court injunction to immediately block Lilly’s weight-loss drug ad...
Biotech and Pharma As Lilly and Novo Clash in Court, Wall Street Is Eyeing This Bigger Prize In this article LLY NVO Eli Lilly is slated to seek regulatory appr...
Eli Lilly and Company has agreed to acquire AtaiBeckley (NasdaqGM:ATAI) in a cash and Contingent Value Right deal valued at up to $3.8b, putting fresh attention...
Analyst ratings
81%
of 31 ratingsMore LLY News
Novo Nordisk (NVO) on Friday said it filed a preliminary injunction to immediately block Eli Lilly (LLY) from running obesity and diabetes drug advertisements i...
Eli Lilly stock has returned roughly 4x over the past five years, yet the current valuation picture is split, with the intrinsic value estimate pointing to mean...
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick...
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Eli Lilly (Symbol: LLY) has taken over the #19 spot...
Technology There's A Hidden Gem In Eli Lilly's Weight-Loss News — And It Could Slam Compounders Licensing Eli Lilly (LLY) said Thursday it will delay filing for...
Biotech and Pharma Lilly Stock Is Rising on Plan to Seek Approval for Newest Weight-Loss Drug in 2027 In this article SPX Eli Lilly’s weight loss drugs have cat...
Pharmaceutical giant Eli Lilly (LLY) says it is targeting the first quarter of 2027 for approval of its next-generation weight-loss drug. Claim 55% Off TipRanks...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.